Green Thumb Industries (GTBIF) Receivables - Net (2019 - 2026)
Green Thumb Industries (GTBIF) posted Receivables - Net of $51.9 million for Q1 2026, up 1.22% on a QoQ basis from $51.3 million in Q4 2025, and up 9.35% year-over-year from $47.5 million in Q1 2025.
Green Thumb Industries (GTBIF) Receivables - Net (2019 - 2026) Analysis & Trends
Green Thumb Industries' Receivables - Net history runs 8 years deep, the most recent figure standing at $51.9 million for Q1 2026.
- Quarterly Receivables - Net rose 9.35% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.9 million (up 9.35% YoY) and the FY2025 annual result came in at $51.3 million, down 2.96% from the prior year.
- Receivables - Net was $51.9 million for Q1 2026 at Green Thumb Industries, up from $51.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $52.8 million in Q4 2024 and bottomed at $25.7 million in Q2 2022.
- A 5-year average of $42.3 million and a median of $46.4 million in 2025 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net surged 68.4% — and 2025, when it decreased 9.05%.
- Green Thumb Industries' Receivables - Net stood at $31.0 million in 2022, then jumped by 38.74% to $43.0 million in 2023, then gained by 22.93% to $52.8 million in 2024, then slipped by 2.96% to $51.3 million in 2025, then increased by 1.22% to $51.9 million in 2026.
- Business Quant data shows GTBIF's Receivables - Net at $51.9 million in Q1 2026, $51.3 million in Q4 2025, and $51.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.90 Mn |
| Mar 31, 2026 | 51.90 Mn |
| Dec 31, 2025 | 51.27 Mn |
| Dec 31, 2025 | 51.27 Mn |
| Sep 30, 2025 | 51.39 Mn |
| Sep 30, 2025 | 51.39 Mn |
| Jun 30, 2025 | 46.45 Mn |
| Jun 30, 2025 | 46.45 Mn |
| Mar 31, 2025 | 47.46 Mn |
| Mar 31, 2025 | 47.46 Mn |
| Dec 31, 2024 | 52.83 Mn |
| Dec 31, 2024 | 52.83 Mn |
| Sep 30, 2024 | 48.96 Mn |
| Sep 30, 2024 | 48.96 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Mar 31, 2024 | 52.18 Mn |
| Mar 31, 2024 | 52.18 Mn |
| Dec 31, 2023 | 42.98 Mn |
| Dec 31, 2023 | 42.98 Mn |